Venus Remedies Limited
VENUSREM · NSE · ₹1,450 a share (close of 05 Nov 2026)
Available company data, source links and archived checks for Venus Remedies Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 13.5%; Net profit rose 27.4% to ₹25.6 crore.
Quarter ended 2026-09-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Sep 2026 | Revenue: ₹219 cr | +13.5% | Net profit: ₹26 cr | +27.4% | 11.7% | Company filing source |
| Jun 2026 | Revenue: ₹179 cr | +35.6% | Net profit: ₹23 cr | +139.3% | 12.8% | Company filing source |
| Mar 2026 | Revenue: ₹259 cr | +33.0% | Net profit: ₹47 cr | +126.1% | 18.3% | Company filing source |
| Dec 2025 | Revenue: ₹180 cr | — | Net profit: ₹26 cr | — | 14.2% | Company filing source |
| Sep 2025 | Revenue: ₹193 cr | — | Net profit: ₹20 cr | — | 10.4% | Company filing source |
| Jun 2025 | Revenue: ₹132 cr | +21.4% | Net profit: ₹10 cr | +686.9% | 7.3% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Sunev Pharma Solutions Pvt Ltd 17.2%PAWAN CHAUDHARY 12.8%MANU CHAUDHARY 11.7%TIKRI PARTNERS LLP 2.0%RAJNI TARUN JAIN 1.4%register as filed
2026-09-30
Filing timeline — what the company told the exchange
- Updates. Venus Remedies Limited has informed the Exchange regarding 'Social Media Communication regarding special window for re-lodgement of transfer requests o
Company disclosure · 05 Nov 2026 · document
- Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication
Company disclosure · 04 Nov 2026 · document
- Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication
Company disclosure · 28 Oct 2026 · document
- Outcome of Board Meeting. Venus Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Company disclosure · 26 Oct 2026 · document
- Updates. Venus Remedies Limited has informed the Exchange regarding 'Venus Remedies Secures Five Marketing Authorisations Across Four Key International Markets'
Company disclosure · 16 Oct 2026 · document
- Updates. Venus Remedies Limited has informed the Exchange regarding 'Social Media Communication regarding special window for re-lodgement of transfer requests'.
Company disclosure · 14 Oct 2026 · document
- Venus Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Company disclosure · 09 Oct 2026 · document
- Updates. Venus Remedies Limited has informed the Exchange regarding 'Intimation regarding change in Corporate Identification Number (CIN).'.
Company disclosure · 30 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time